Plain-English Summary
AHA marijuana brain health in Scientific-statement audience; consumer and clinician context. Marijuana brain-health claims require age, dose, product, route, and vulnerability context.
VV Study Evidence Matrix v1.0
VV Evidence Utility Score
A bounded score for how useful this study is in public explanation, based on evidence tier, design, applicability, endpoint relevance, limitations, safety signals, and publication/source strength.
69/100
Limited Public Evidence
- Evidence tier
- 78/100, weight 18%
- Design strength
- 78/100, weight 18%
- Applicability
- 75/100, weight 16%
- Endpoint relevance
- 58/100, weight 16%
- Limitations transparency
- 50/100, weight 12%
- Safety signal usefulness
- 45/100, weight 10%
- Publication/source strength
- 88/100, weight 10%
Useful for context, but limited by safety signal usefulness, limitations transparency, endpoint relevance.
How the study framework works ->Key Findings
- Marijuana brain-health claims require age, dose, product, route, and vulnerability context.
- Cardiovascular and neurologic risk framing should avoid one-slogan certainty.
- Statement-level synthesis supports caution without proving every viral claim.
Limitations
- Synthesis/guidance context, not a randomized cannabis trial.
Why It Matters
Evidence synthesis on marijuana exposure and brain-health risk framing.
Viral Vitalism Verdict
Useful evidence, bounded by design: Synthesis/guidance context, not a randomized cannabis trial.
Sources
- Use of Marijuana: Effect on Brain Health - American Heart Association / Stroke
Signal cards
Used in signals
Signal coverage connected to this study through explicit study links, canonical source refs, or evidence visualizations.
Does Cannabis Shrink Your Brain?
A viral claim turns cannabis brain research into a one-line shrinkage scare. The evidence is messier: blood flow, activation, volume, cognition, age, dose, and heavy-use patterns are not interchangeable.
VV Signal Score
58
Early or context-dependent
- Sources
- 10
- Studies
- 7
- Claims
- 7
Claim ledger
Relevant claims
Claim ledger records connected through this study's ID, topic tags, or source IDs.
cannabis: Cannabis brain and cognition risk depends heavily on age,
Cannabis brain and cognition risk depends heavily on age, frequency, potency, recency, route, dependence, vulnerability, and co-use.
cannabis: The broad claim that cannabis shrinks your brain overstates
The broad claim that cannabis shrinks your brain overstates a mixed evidence base and swaps endpoints such as perfusion, activation, volume, and cognition.
cannabis: Cannabis brain-volume evidence varies by population, exposure pattern, age
Cannabis brain-volume evidence varies by population, exposure pattern, age at first use, co-use, measurement method, and confounding.
cannabis: Older-adult cannabis brain-volume counter-signals break the simple shrinkage meme
Older-adult cannabis brain-volume counter-signals break the simple shrinkage meme but do not prove cannabis protects the aging brain.
brain imaging: A SPECT perfusion or blood-flow finding should not be
A SPECT perfusion or blood-flow finding should not be described as proof of structural brain shrinkage.
cannabis: Heavy lifetime cannabis use has been associated with lower
Heavy lifetime cannabis use has been associated with lower working-memory task activation in young-adult fMRI data.